| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615138 | Journal of Clinical Lipidology | 2017 | 28 Pages |
Abstract
OM3-CA can be administered with either rosuvastatin or simvastatin without affecting the pharmacokinetics of these statins.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Elliot PhD, Michael MD, Catarina MSc,